Medications for Acute Myeloid Leukemia (AML)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Acute Myeloid Leukemia (AML).
Found 17 Approved Drugs for Acute Myeloid Leukemia (AML)
AzaCITIDine
Brand Names
Vidaza, Onureg
AzaCITIDine
Brand Names
Vidaza, Onureg
Form: Injection, Tablet
Method of administration: Subcutaneous, Intravenous, Oral
FDA approval date: July 05, 2004
Classification: Nucleoside Metabolic Inhibitor
Azacitidine for injection is a nucleoside metabolic inhibitor indicated for the treatment of: · Adult patients with the following FAB myelodysplastic syndrome (MDS) subtypes: Refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).
Clindamycin
Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Altreno, Benzaclin, Twyneo, Atralin, ZIANA, Tri-Luma, Vesanoid, Clindagel, Retin-A, Acanya, Renova, Onexton
Clindamycin
Brand Names
ClindaCare, Cleocin, Xaciato, Neuac, Clindacin ETZ, Tretinion, Clindesse, Clindacin, Tretinoin, Clindamycin Phoaphate, Altreno, Benzaclin, Twyneo, Atralin, ZIANA, Tri-Luma, Vesanoid, Clindagel, Retin-A, Acanya, Renova, Onexton
Form: Solution, Lotion, Injection, Suppository, Cream, Aerosol, Kit, Granule, Powder, Swab, Capsule, Gel
Method of administration: Oral, Intravenous, Vaginal, Intramuscular, Topical
FDA approval date: May 22, 1970
Classification: Lincosamide Antibacterial
TWYNEO is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. TWYNEO is a combination tretinoin, a retinoid, and benzoyl peroxide indicated for the topical treatment of acne vulgaris in adults and pediatric patients 9 years of age and older. ( 1 )
Daunorubicin
Generic Name
Daunorubicin
Daunorubicin
Generic Name
Daunorubicin
Form: Injection
Method of administration: Intravenous
FDA approval date: January 02, 2018
Classification: Anthracycline Topoisomerase Inhibitor
Daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.
Idamycin PFS
Generic Name
Idarubicin
Idamycin PFS
Generic Name
Idarubicin
Form: Injection, Solution
Method of administration: Intravenous
FDA approval date: February 17, 1997
Classification: Anthracycline Topoisomerase Inhibitor
IDAMYCIN PFS Injection in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in adults. This includes French-American-British (FAB) classifications M1 through M7.
DOXOrubicin
Brand Names
Doxil, Adriamycin
DOXOrubicin
Brand Names
Doxil, Adriamycin
Form: Injection, Injectable
Method of administration: Intravenous, Intravitreal
FDA approval date: December 23, 1987
Classification: Anthracycline Topoisomerase Inhibitor
Doxorubicin is an anthracycline topoisomerase II inhibitor indicated: as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer.
Showing 1-5 of 17
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances